The six centres form part of a wider network of 15 brain tumour centres for children, which have been established following a ...

Postgraduate doctors account for more than 50,000 NHS staff in England and are set to benefit from greater flexibility, less ...

The phase 3 trial is investigating the combination of mRNA-4157 – otherwise known as V940 – and pembrolizumab, which is sold ...

For episode 43 of the National Health Executive podcast, we were joined by Dr Penny Kechagioglou, who is a Consultant ...

Giving an update on the Scottish Government ’s response to the review, which was chaired by Dr Hilary Cass, the minister also ...

The report stresses that more patients are being seen overall – 6.1 million patient pathways were completed from December ...

National Health Executive’s dedicated IT infrastructure online conference will give healthcare leaders from across the sector ...

James will replace long-term chief executive, Heidi Travis, who made the decision to “semi-retire” last November after 14 ...

The BMA highlight that, at the very least, this has cost the health service and taxpayers between £1.6bn to £2.4bn. The cost ...

The saving is based on the estimation that fragility fractures in social care cost the NHS £1.1bn a year, and the cost of the ...

Dabrafenib, marketed as Finlee, in combination with trametinib, which is sold as Spexotras, (both made by Novartis) is being ...

National clinical director for diabetes and obesity at NHS England (NHSE), Dr Clare Hambling, said: “These results are ...